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Neointima formation is promoted by surgical 
preparation and inhibited by cyclic nucleotides 
in human saphenous vein organ cultures 
Intimal thickening isan important cause of late coronary vein graft occlusion, which novariation of 
surgical technique or pharmacologic ntervention has been shown to reduce. We used a recently 
developed quantitative organ culture of human saphenous vein to investigate whether surgical 
preparative injury promotes neointima formation. We also investigated the effects on neointima 
formation of the lipid-soluble cyclic nucleotide analogs, 8-Br-cyclic adenosine monophosphate nd 
8-Br-cyclic guanosine monophosphate, and the phosphodiesterase inhibitor, isobntylmethylxan- 
thine. These agents are pharmacologic mimetics of endothelium-derived prostacyclin and itric 
oxide, which elevate vascular smooth muscle cyclic adenosine monophosphate nd cyclic guanosine 
monophosphate concentrations, respectively, and may normally suppress neointima formation. 
Surgical preparation was found to promote intimal thickening and neointimal smooth muscle cell 
proliferation by 42% and 48%, respectively. 8-Br-cyclic adenosine monophosphate, 8-Br-cyclic 
guanosine monophosphate, or isobutylmethylxanthine (which elevated endogenous cyclic adenosine 
monophosphate concentrations) inhibited intimal thickening by 80%, 40%, and 72%, respectively, at 
a concentration f 0.1 mmol/L. The results imply that surgical techniques that avoid preparative 
injury and vasodilator drugs that act by elevating cyclic adenosine monophosphate or cyclic 
guanosine monophosphate concentrations may reduce neointima formation n vein grafts. (J 
THORAC CARDIOVASC SURG 1995;109:2-12) 
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I ntimal thickening is a key contributor to late 
arteriovenous graft occlusion. 1-3 It is caused by 
migration and proliferation of vascular smooth mus- 
cle cells and laying down of extracellular matrix. 
Intimal thickening may critically narrow the graft 
lumen in itself or may promote atheroma formation 
leading to further stenosis. 
Proliferation of vascular smooth muscle cells 
probably results from the action of several endog- 
enously produced growth factors, the most impor- 
tant of which may be platelet-derived growth fac- 
tor 4'5 and basic fibroblast growth factor. 6'7 The 
causes of growth factor production in vein grafts is 
uncertain, although wall stress 8 and injury 9 have 
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both been implicated. Cell injury appears to be 
necessary, in particular, for release of basic fibro- 
blast growth factor from cells, w A relationship 
between surgical preparative injury and the extent of 
subsequent vein graft intimal thickening has been 
suggested in animal models on the basis of semi- 
quantitative morphologic riteria. 11' ~20verdisten- 
tion of vein, ~3' 14 used to reverse pasm, and expo- 
sure to solutions of low oncotic pressure 15 or low 
temperature14, 6  17 have been implicated as causes 
of this injury. In this study, the influence of surgical 
preparation on neointima formation was investi- 
gated quantitatively in a recently developed organ 
culture of human saphenous vein. 9' 18 
Pharmacologic strategies to inhibit neointima for- 
mation have included attempts to inhibit mitogen 
release from platelets, 19 although this appears to 
limit thrombosis rather than neointima formation. 2° 
The use of agents that have direct antimitotic activ- 
ity on vascular smooth muscle cells probably repre- 
sents the most attractive route. Experiments with 
heparin 21'22 have been disappointing, however, 
probably because of the low potency of this agent. 
Elevation of intracellular adenosine 3',5'-cyclic 
monophosphate (cAMP) 23-29 or guanosine 3',5'- 
cyclic monophosphate (cGMP) 29-31 has been shown 
to inhibit the proliferation of vascular smooth mus- 
cle cells. Because endothelium-derived prostaglan- 
dins and nitric oxide can elevate cAMP and cGMP 
concentrations, respectively, in vascular smooth 
muscle cells, 32 cyclic nucleotides may exert tonic 
control of their proliferation, which might be poten- 
tiated pharmacologically b cyclic nucleotide phos- 
phodiesterase inhibitors. Alternatively, the effect of 
cAMP and cGMP elevation might be mimicked by 
membrane-permeable cyclic nucleotide analogs. In 
this study, the possible inhibitory effects on neointima 
formation of 8-Br-cAMP, 8-Br-cGMP, and the nonse- 
lective cyclic nucleotide phosphodiesterase inhibitor, 
3-isobutyl-l-methylaxanthine (IBMX), were also inves- 
tigated in the organ culture model. 
Materials and methods 
Paired segments of freshly isolated and surplus surgi- 
cally prepared saphenous vein were obtained from 33 
patients (mean age 60.4 years; range 38 to 73 years; 7 
women) who were undergoing coronary artery bypass 
grafting. Ethical permission was obtained from the rele- 
vant authority. Freshly isolated Segments were obtained 
immediately after dissection by a "no-touch" technique. 33
Surgically prepared segments had been subjected to side 
branch ligation, adventitial stripping, and uncontrolled 
manual distention with the patient's heparinized blood 
followed by storage in the same medium for 60 to 120 
minutes.9.14 Segments were obtained after completion of 
the last proximal anastomosis. 
Vein segments were collected in tissue culture medium 
(RPMI 1640 with HEPES buffer, 20 mmol/L, pH 7.4) 
containing heparin sodium, 4 IU/ml (CP Pharmaceuticals, 
Wrexham, United Kingdom), papaverine hydrochloride, 
0.2 mg/ml (McCarthy Medical, Essex, United Kingdom), 
and amphotericin B, 5 /xg/ml (Flow Labs, Irvine, Calif.), 
and transferred to the laboratory at room temperature. 
Tissue culture and vein preparation procedures. Vein 
segments were cleaned free of excess fat and connective 
tissue under sterile conditions, opened with the luminal 
surface uppermost, and cut into 1 cm lengths. Vein 
segments were then incubated in RPMI 1640 medium 
containing sodium bicarbonate, 2 gm/L, supplemented 
with 30% fetal bovine serum (Imperial Labs, Hants, 
United Kingdom), gentamicin, 2.5 ~g/ml (David Bull 
Labs, Warwick, United Kingdom), penicillin:streptomy- 
cin, 100 /~g/ml (Flow Labs), and glutamine, 2 mmol/L 
(Flow Labs), and maintained for 14 days at 37 ° C in 5% 
carbon dioxide in an air incubator. Tissue culture medium 
was changed every 48 to 72 hours and was supplemented 
with [6-3H]thymidine (5 Ci/mmol; Amersham Interna- 
tional, Aylesbury, Bucks, United Kingdom) for the last 24 
hours in culture. 8-Br-cAMP, 8-Br-cGMP, and IBMX 
were purchased from Sigma (Poole, Dorset, United King- 
dom). 8-Br-cAMP and 8-Br-cGMP were dissolved to 0.1 
mmol in tissue culture medium and sterilized by filtration. 
IBMX was dissolved in dimethylsulfoxide and diluted with 
tissue culture medium to yield a final concentration 0.1 
mmol IBMX and 0.1% dimethylsulfoxide. The culture 
medium was supplemented with the appropriate pharma- 
cologic agent throughout the culture period. For the 
experiments with IBMX, control cultures were performed 
with medium containing 0.1% dimethylsulfoxide. 
At the end of the culture period, the vein segments were 
bisected and one portion was immediately placed into 
liquid nitrogen while the other was fixed in phosphate 
buffer, 0.1 mol (pH 7.2), containing 10% formaldehyde, 
The frozen vein segments were pulverized under liquid 
nitrogen, extracted with perchloric acid, 34 and the soluble 
fractions were neutralized by paired ion extraction. 3s 
Measurements of purine metabolites by high-perfor- 
mance liquid chromatography, a4 deoxyribonucleic acid by 
fluorimetry, 36and total [3H]thymidine incorporation by 
liquid scintillation spectrometry 37 were then carried out as 
described previously, as The concentrations of cAMP and 
cGMP were measured in neutralized soluble fractions of 
the same extracts by radioimmunoassay using commer- 
cially available kits (Amersham International, RPA 508 
and RPA 525, respectively). 
The fixed vein segments were embedded inparaffin and 
transverse ctions (5 txm thick) were then cut and stained 
with Miller's elastic and van Gieson stain. 3s Intimal 
thickening in culture was measured with a calibrated 
graticule at 5 to 10 points on two sections from each vein. 
To count [3H]thymidine-labeled cells, we subjected un- 
stained sections to autoradiography b  coating with K2 
nuclear emulsion (Ilford Ltd., Cheshire, United Kingdom) 
18 as previously described and counterstained with Harris 
hematoxylin and eosin. 38 Neointimal and medial cells 
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Fig. 1. Intimal surface structure. Scanning electron micrographs of representatives of 20 replicate vein 
segments examined under each of the following conditions: a, Freshly isolated vein after preparation f r
culture, b, Freshly isolated vein after 14 days in culture, e, Surgically prepared vein after preparation for 
culture; note that the endothelium is partly disrupted, d, Surgically prepared vein after 14 days in culture; 
note that the endothelial coverage has been largely restored, although there are lamellipodia (L) spanning 
the gaps between endothelial cells. (The scale bar = 10/~m.) 
labeled with more than about 20 silver grains were 
counted in three sections from each vein and related to 
the intimal ength or intimal ength × medial thickness off 
the section, respectively, which were measured with a 
calibrated graticule, as described earlier. The total num- 
ber of nuclei n the neointimal layer was also counted. 
Results 
Effect of surgical preparation. Freshly isolated 
veins had a significantly higher adenosine triphos- 
phate (ATP) concentration than surgically prepared 
veins (164 _+ 24 versus 86 ___ 15 nmol/mg wet weight, 
standard error of the mean, n = 25,p < 0.01, paired 
t test). The ratio of adenosine triphosphate/diphos- 
phate (ATP/ADP) concentration was similarly de- 
creased by surgical preparation from 1.28 __- 0.16 to 
0.75 _+ 0.10 (p < 0.01). This confirmed that surgical 
preparation caused metabolic injury, as previously 
reported.9, 14, 39 Scanning electron microscopy con- 
firmed also that freshly isolated veins had an intact 
endothelium but that surgically prepared veins had 
partial endothelial injury (Fig. 1, a compared to c). 
Culture in serum for 14 days led to the develop- 
ment of a neointima visible as an elastin-poor layer 
in transverse histologic sections tained with Miller's 
elastic-van Gieson stain (Fig. 2, a compared to b). 
Proliferating smooth muscle cells were observed in 
[3H]thymidine autoradiograms in the neointima 
(Fig. 2, d compared to e) and less frequently in the 
media (not shown). The histologic appearance of 
the neointima was similar in cultured, freshly iso- 
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Fig. 2. Transverse sections of veins, a, A transverse section (5 txm) of a surgically prepared vein before 
culturing, stained with Miller's elastic and van Gieson. Note elastic stain extending up to the lumen, b, A 
similar section of a surgically prepared vein after culturing for 14 days in serum alone. Note the lightly 
stained new intima above the internal elastic layer (small arrows), c, A similar section of a surgically 
prepared vein after culturing for 14 days in serum with 8-Br-cAMP, 0.1 mmol/L. The new intima is greatly 
attenuated. 
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Fig. 2" Cont'd. d, An autoradiogram counterstained with Harris' hematoxylin and eosin of a near-serial 
section to a. There are no silver-stained nuclei, e, A similar autoradiogram near-serial to b. Labeled cells 
(large arrows) are concentrated in the new intima above the internal elastic layer (small arrows), f A similar 
autoradiogram near-serial to c. There are no silver stained nuclei. The scale bar applies to all panels and 
represents 50/xm. 
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Fig. 3. Unpaired comparison of the effects of surgical preparation, cyclic nucleotides, and IBMX. Freshly 
isolated (F1) (n = 28) and surgically prepared (SP) veins (n = 33) were cultured for 14 days in serum. 
Further segments of surgically prepared vein were cultured in serum supplemented with 0.1 mmol of 
8-Br-cAMP (n = 16), 8-Br-cGMP (n = 12), or IBMX (n = 8) as indicated. The following parameters were 
measured from transverse sections: a, Intimal thickness, b, The number of thymidine-labeled cells per 
millimeter of intimal ength, c, The number of thymidine-labeled cells per square millimeter of media. 
*p < 0.001 versus surgically prepared vein cultured in serum alone (unpaired t test). For paired 
comparisons see Tables I to IV. 
lated, and surgically prepared veins, both in trans- 
verse sections (not shown) and in scanning micro- 
graphs (Fig. 1, b and d). 
Surgically prepared veins showed 42% greater 
intimal thickening during culture, associated with a 
48% increase in the number of thymidine-labeled 
neointimal cells and a 56% increase in the neointi- 
mal thymidine index (Fig. 3, Table I). Medial pro- 
liferation was also significantly more prevalent in 
cultured surgically prepared veins (Fig. 3, Table I). 
ATP concentration, a marker of viable cell numbers, 
was similar in cultures of surgically prepared veins 
and freshly isolated veins, despite the lower starting 
values (Table I). This observation is consistent with 
there being compensatory cell proliferation in sur- 
gically prepared veins, although deoxyribonucleic 
acid concentrations remained 20% lower than in 
cultured freshly isolated veins (Table I). The higher 
ratios of ATP/ADP concentration i  cultured surgi- 
cally prepared veins (Table I) suggests that more of 
the cells in these cultures had transformed into a 
synthetic phenotype, because synthetic-state vascu- 
lar smooth muscle cells have a higher value of this 
parameter than contractile-state c lls. 28 
Table I. Effect of surgical preparation 
Freshly Surgically 
isolated veins prepared veins 
Intimal thickness (/~m) 
Intimal [3H]thymidine cells/mm 
Intimal [3H]thymidine index (%) 
Medial [3H]thymidine cells/mm 2 
ATP (nmol/gm wet weight) 
ATP/ADP ratio 
DNA (txg/mg wet weight) 
33 4- 4 47 +_ 6* 
6.7 -+ 1.1 9.9 -+ 1.4" 
5.3 -+ 0.7 8.3 + 1.0t 
0.8 -+ 0.2 5.2 -+ 1.57 
186 + 19 188 _+25 
2.9 -+ 0.2 4.54 +- 0.55? 
0.53 _+ 0.05 0.41 _+ 0.04* 
Paired segments of freshly isolated and surgically prepared veins from 26 
patients were cultured for 14 days with [3H]thymidine present for the last 
24 hours. ATP, ADP, and deoxyribonucleic (DNA) concentrations and 
total [3H]thymidine incorporation were measured in perehloric acid ex- 
tracts of frozen pulverized tissue. Other parameters were measured on 5 
tzm thick transverse sections of formalin-fixed vein segments. 
*p < 0.05 versus freshly isolated veins (paired Student's t test). 
1"p < 0.01 versus freshly isolated veins (paired Student's t test). 
Effects of cyclic nucleotides and IBMX. Only 
surgically prepared veins were used for this study 
because of their availability in larger amounts than 
freshly-isolated veins. 8-Br-cAMP decreased intimal 
thickening by 80%, 8-Br-cGMP decreased it by 
40%, and IBMX decreased it by 72% (Fig. 3, a, 
Tables II to IV). 8-Br-cAMP and 8-Br-cGMP also 
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Table II. Effect of 8-Br-cAMP 
Experiment 
Control." Controk 8-Br-cAMP." 
day 0 day 14 day 14 
Intimal thickness 50 -- 10 10 -+ 2t 
(/~m) 
Intimal [3H]thymidine 9.8 --+ 1.8 1.6 --- 0.5I" 
eells/mm 
Intima| [3H]thymidine 8.5 -+ 1.4 3.42 -4- 0.8* 
index (%) 
Medial [3H]thymidine 8.3 - 2.8 1.7 -- 0.8* 
cells/mm 2 
ATP (nmol/gm wet 80 _+ 20 170 _+ 20~ 110 --- 10t 
weight) 
ATP/ADP ratio 0.63 _+ 0.13 4.6 _+ 0.8§ 5.7 -+ 1.2§ 
DNA (/zg/mg wet 0.4 -4- 0.03 0.33 + 0.03 0.28 + 0.03"~: 
weight) 
Replicate segments ofveins from 15 patients were cultured for 14 days with 
and without 8-Br-cAMP (0.1 mmol/L) and with [3H]thymidine for the last 
24 hours. 
*p < 0.05 versus control, day 14 (paired Student's t test). 
tp < 0.001 versus control, day 14 (paired Student's t test). 
:~p < 0.05 versus control, day 0 (paired Student's t test). 
§p < 0.001 versus control, day 0 (paired Student's t test). 
Table IV. Effect of lBMX 
Experiment 
Control." Control." IBMX: 
day 0 day 14 day 14 
Intimal thickness 40 - 6 12 --_ 4t 
(/~m) 
Intimal [3H]thymidine 7.4 + 2.7 4.2 -4- 1.5 
cells/mm 
lntimal [3H]thyrnidine 8.0 4- 1.8 9.3 ___ 2.9 
index (%) 
Medial [3H]thymidine 9.4 + 2.9 2.4 _+ 1.1" 
cells/mm 2 
ATP (nmol/gm wet 80 -+ 30 200 --- 25:~ 125 _+ 30* 
weight) 
ATP/ADP ratio 0.68 ___ 0.2 6.2 + 0.85§ 6.0 -4- 1.3§ 
DNA (/zg/mg wet 0.33 -+ 0.05 0.38 -+ 0.05 0.27 _ 0.05* 
weight) 
Replicate segments ofveins from 8 patients were cultured for 14 days with 
and without IBMX (0.1 mmol/L) and with [3H]thymidine for the last 24 
hours. 
*p < 0.05 versus control, day 14 (paired Student's t test). 
tp < 0.001 versus control, day 14 (paired Student's t test). 
:~p < 0.05 versus control, day 0 (paired Student's t test). 
§p < 0.001 versus control, day 0 (paired Student's t test). 
Table III. Effect of 8-Br-cGMP 
Experiment 
Control." Control." 8-Br-cGMP: 
day 0 day 14 day 14 
Intimal thickness 53 - 13 30 _+ 10t 
(~m) 
Intimal [3H]thymidine 7.9 - 1.8 5.6 _+ 1.7" 
cells/ram 
Intimal [3H]thymidine 6.1 --- 0.9 5.6 -+ 1.1 
index (%) 
Medial [3H]thymidine 4.9 -+ 1.9 2.4 -+ 0.7 
cells/mm 2 
ATP (nmol/gm wet 91 _+ 27 170 -+ 30:~ 180 --- 30~: 
weight) 
ATP/ADP ratio 0.74 _+ 0.16 4.1 _ 0.70§ 4.8 - 0.9§ 
DNA (/xg/mg wet 0.35 _+ 0.03 0.29 -+ 0.03 0.25 -+ 0.03:~ 
weight) 
Replicate segments ofveins from 11 patients were cultured for 14 days with 
and without 8-Br-cGMP (0.I mmol/L) and with [3H]thymidine for the last 
24 hours. 
*p < 0.05 versus control, day 14 (paired Student's t test). 
tp < 0.001 versus control, day 14 (paired Student's t test). 
~:p < 0.05 versus control, day 0 (paired Student's t test). 
§p < 0.001 versus control, day 0 (paired Student's t test). 
decreased the number of [3H]thymidine-labeled 
cells in the neointima (Fig. 3, b) and 8-Br-cAMP the 
neointimal thymidine i dex (Table II), although 
neither effect was seen with IBMX (Fig. 3, b, Table 
IV). Medial proliferation was inhibited (Fig. 3, c) 
significantly by 8-Br-cAMP (Table II) and IBMX 
(Table IV), whereas the inhibitory effects of 8-Br- 
cGMP (Table III) just failed to reach significance 
Co = 0.1).  
None of 8-Br-cAMP (Table II), 8-Br-cGMP (Ta- 
ble III), or IBMX (Table IV) caused a decline in 
ATP concentration tovalues below those observed 
on day 0, which implies that they did have a cyto- 
toxic action. 8-Br-cAMP and IBMX, however, pre- 
vented the increase in ATP concentration that oc- 
curred uring culture and significantly depressed the 
concentration f deoxyribonucleic acid (8-Br-cGMP 
showed an inhibitory trend, p = 0.06). This infor- 
mation provides further evidence that 8-Br-cAMP 
and IBMX inhibited proliferation, thereby decreas- 
ing the final number of viable cells. None of the 
agents affected the ratio of ATP/ADP concentra- 
tion, which implies that they did not inhibit pheno- 
typic modulation. 
To clarify the basis for the inhibitory effects of 
IBMX, we measured cyclic nucleotide concentra- 
tions. The concentration f cAMP was not increased 
by culturing in the presence of serum with or 
without 0.1% dimethylsulfoxide (vehicle for IBMX) 
(Table V). By contrast, cOMP concentration was 
significantly elevated by culturing for i day in serum 
with or without dimethylsulfoxide. Culturing tended 
to increase cGMP after 14 days also. This may be 
due to stimulation of endothelial nitric oxide pro- 
duction by agents such as serotonin, which are 
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Table V. Effect of IBMX on intracellular cyclic nucleotide concentrations 
cAMP (pmol/Ixg DNA) cGMP (fmol/ixg DNA) 
Nucleotide Day 0 Day 1 Day 14 Day 0 Day 1 Day 14 
Control  1.1 -+ 0.2 1.0 _+ 0.2 1.0 _+ 0.2 32 _+ 4 260 _+ 80? 70 ± 40 
DMSO (0.1%) 1.1 ± 0.2 1.0 + 0.1 150 _+ 50 40 ± 8 
IBMX (0.1 retool/L) 1.8 ± 0.2* 0.9 _+ 0.1 150 +_ 50 60 _+ 20 
Replicate segments of veins from 10 patients were cultured for 1 or 14 days with and without IBMX (0.1 mmol/L). Cyclic nucleotide concentrations were 
measured by radioimmunoassay in perchloric acid extracts of frozen pulverized tissue. 
*p < 0.05 versus control on the same day (paired Student's t test). 
tp < 0.05 versus control on day 0 (paired Student's t test). 
known to be present in fetal calf serum. 4° IBMX 
significantly increased cAMP concentration after 1 
day, but not after 14 days (Table V), and did not 
affect cGMP concentration ateither time (Table V).
The effects of IBMX are more likely therefore to 
have resulted from cAMP than cGMP elevation. 
Discussion 
To our knowledge, these results provide the first 
direct quantitative vidence that surgical prepara- 
tive injury promotes neointimal thickening and neo- 
intimal proliferation of vascular smooth muscle 
cells. A previous qualitative morphologic study in 
dogs reached the same conclusion, 11 but a quantita- 
tive study in pigs found no difference. 41The study in 
pigs, 41 however, considered only patent grafts. Be- 
cause surgical preparation was significantly corre- 
lated with early graft occlusion, 42 these patent grafts 
were probably those least injured among the "sur- 
gically prepared" group. The effect of surgical prep- 
aration may have been thereby obscured. In a 
previous organ culture study, 9we found that surgical 
preparation increased medial proliferation, as con- 
firmed here, but not neointimal proliferation. In 
that study, 9labeling with [3H]thymidine was carried 
out continuously rather than for the last 24 hours 
only. As a result, the final neointimal thickening was 
less (30/xm 9versus 47 /xm [present data] in surgi- 
cally prepared veins), probably owing to the known 
antiproliferative effect of [3H]thymidine.43 This in- 
hibition may have counteracted the stimulatory ef- 
fect of surgical preparation. In addition, the differ- 
ences observed in this study were based on 
comparison of a larger group (n = 26). 
The data presented here further demonstrate hat 
analogs of cAMP and cGMP inhibit neointimal and 
medial proliferation f vascular smooth muscle cells 
in human saphenous vein at concentrations equal to 
or less than those previously shown to inhibit other 
preparations of vascular smooth muscle cells. 29' 44 
IBMX, a cyclic nucleotide phosphodiesterase inhib- 
itor that increased endogenous cAMP concentra- 
tions by only twofold after 1 day, was almost as 
effective as 8-Br-cAMP. This underlines the sensi- 
tivity of human smooth muscle cells to inhibition by 
cAMP. The failure of IBMX to sustain elevated 
cAMP concentrations for 14 days probably explains 
why the thymidine index over the last 24 hours of 
culture was not affected. The decline in cAMP 
concentrations may be because the production of 
prostacyclin (a likely stimulator of endogenous 
cAMP concentration in veins) decreases during 
culture (AA Soyombo, AC Newby, unpublished 
observations). The inhibitory effect of 8-Br-cGMP 
occurred at concentrations tenfold lower than in 
previous studies 29-31 and just sufficient to cause 
vascular relaxation. This implies that vasodilator 
concentrations of endothelium-derived nitric oxide 
exert a tonic inhibitory control on proliferation of 
human vascular smooth muscle cells that may be lost 
after vein grafting. 45 
How far can these data be extrapolated to the 
clinical situation? Organ culture generates a rapid 
intimally directed proliferation of vascular smooth 
muscle cells, as seen in early vein grafts. In organ 
culture, as in vivo and as opposed to isolated cell 
culture models, vascular smooth muscle cells are 
initially in a contractile state and are in close 
proximity to endothelial cells and extracellular ma- 
trix components. In organ culture, proliferation is 
stimulated by serum rather than by endogenous or 
platelet-derived mitogens, as in vivo. However, se- 
rum provides a similar combination of mitogens 
(including platelet-derived growth factor and basic 
fibroblast growth factor) to those likely to be present 
in vein grafts. Furthermore, the inhibitors studied 
here are likely, from previous work, to be effective 
irrespective of the pathway of mitogenesis. 46 
The results of this study imply therefore that vein 
graft intimal thickening can be ameliorated by 
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avoiding surgical preparative injury. Several simple 
protocols have been described to avoid medial in- 
jury caused by overdistention by using either a 
pressure-limiting device 13 or arterial pressure 47'48 
when checking the competence of side-branch liga- 
tures. Endothelial disruption can be reduced by 
avoiding manipulation that leads to abrasion of the 
intimal surface. 17 Avoidance of injury was shown to 
improve early patency in a pig model. 4z Conversely, 
distention of vein was shown to promote graft 
atherosclerosis by increasing cholesterol and li- 
poprotein deposition in grafts of hypercholester- 
olemic primates. 49 In the absence of a definitive 
clinical trial, the present study adds to the weight of 
experimental evidence favoring the use of atrau- 
matic methods of vein preparation. 
Postoperative pharmacologic intervention, as well 
as optimal surgical preparative technique, is needed 
to improve long-term patency. Only lipid-lowering 
therapy has so far been shown to decrease lesion 
formation in vein grafts, s° Potent inhibitors of pro- 
liferation of vascular smooth muscle cells have not 
been available for clinical studies, however. The 
results of this study indicate that cAMP and cGMP 
pathways are possible therapeutic targets. Although 
neither 8-Br-cAMP nor IBMX could be used in 
man, agents with similar actions are available for 
clinical studies. Stable analogs of prostacyclin and 
selective cAMP phosphodiesterase inhibitors (e.g., 
milrinone) have been shown to exert vasodilator 
effects, l mediated by elevation of cAMP concentra- 
tion in vascular smooth muscle cells. It will be 
important o establish, in animal studies initially, 
whether significant inhibition of proliferation of 
vascular smooth muscle cells in vein grafts can be 
achieved without excessive vasodilatation or other 
side effects uch as positive inotropy, sl On the basis 
of our data, nitrovasodilators or specific cGMP 
phosphodiesterase inhibitors may also be useful. A 
particularly exciting therapeutic possibility is raised 
by the recent cloning of nitric oxide synthase, 2 
Transfer of this gene (for example, in liposomes or 
by retrovirus) into saphenous vein at the time of 
grafting could lead to continuous nitric oxide pro- 
duction and localized inhibition of intimal thicken- 
ing. 
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